Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma. Issue 2 (1st February 2022) - Laribi, Kamel; Baugier de Materre, Alix; Touileb, Yamina; Boursot, Charles; Sandrini, Jeremy; Cavalieri, Doriane; Pastoret, Cédric; de Leval, Laurence; Tournilhac, Olivier